193 related articles for article (PubMed ID: 28416638)
1. Eya2, a Target Activated by Plzf, Is Critical for
Ono R; Masuya M; Ishii S; Katayama N; Nosaka T
Mol Cell Biol; 2017 Jul; 37(13):. PubMed ID: 28416638
[TBL] [Abstract][Full Text] [Related]
2. Eya2 is critical for the E2A‑HLF‑mediated immortalization of mouse hematopoietic stem/progenitor cells.
Maharjan BD; Ono R; Nosaka T
Int J Oncol; 2019 Mar; 54(3):981-990. PubMed ID: 30628662
[TBL] [Abstract][Full Text] [Related]
3. Plzf drives MLL-fusion-mediated leukemogenesis specifically in long-term hematopoietic stem cells.
Ono R; Masuya M; Nakajima H; Enomoto Y; Miyata E; Nakamura A; Ishii S; Suzuki K; Shibata-Minoshima F; Katayama N; Kitamura T; Nosaka T
Blood; 2013 Aug; 122(7):1271-83. PubMed ID: 23838347
[TBL] [Abstract][Full Text] [Related]
4. The deubiquitinating enzyme USP37 regulates the oncogenic fusion protein PLZF/RARA stability.
Yang WC; Shih HM
Oncogene; 2013 Oct; 32(43):5167-75. PubMed ID: 23208507
[TBL] [Abstract][Full Text] [Related]
5. The DNA binding property of PML/RARA but not the integrity of PML nuclear bodies is indispensable for leukemic transformation.
Liu X; Yuan H; Peres L; Chen S; Chen Z; de The H; Zhou J; Zhu J
PLoS One; 2014; 9(8):e104906. PubMed ID: 25119106
[TBL] [Abstract][Full Text] [Related]
6. [hCG-PLZF-RARA transgenic mice develop leukemia resembling human chronic myeloid leukemia].
Meng X; Cheng G; Wang L
Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):22-5. PubMed ID: 11776589
[TBL] [Abstract][Full Text] [Related]
7. Gamma-catenin contributes to leukemogenesis induced by AML-associated translocation products by increasing the self-renewal of very primitive progenitor cells.
Zheng X; Beissert T; Kukoc-Zivojnov N; Puccetti E; Altschmied J; Strolz C; Boehrer S; Gul H; Schneider O; Ottmann OG; Hoelzer D; Henschler R; Ruthardt M
Blood; 2004 May; 103(9):3535-43. PubMed ID: 14739224
[TBL] [Abstract][Full Text] [Related]
8. Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation.
Nasr R; Guillemin MC; Ferhi O; Soilihi H; Peres L; Berthier C; Rousselot P; Robledo-Sarmiento M; Lallemand-Breitenbach V; Gourmel B; Vitoux D; Pandolfi PP; Rochette-Egly C; Zhu J; de Thé H
Nat Med; 2008 Dec; 14(12):1333-42. PubMed ID: 19029980
[TBL] [Abstract][Full Text] [Related]
9. Immortalization of human AE pre-leukemia cells by hTERT allows leukemic transformation.
Lin S; Wei J; Wunderlich M; Chou FS; Mulloy JC
Oncotarget; 2016 Aug; 7(35):55939-55950. PubMed ID: 27509060
[TBL] [Abstract][Full Text] [Related]
10. Sulindac sulfide reverses aberrant self-renewal of progenitor cells induced by the AML-associated fusion proteins PML/RARα and PLZF/RARα.
Steinert G; Oancea C; Roos J; Hagemeyer H; Maier T; Ruthardt M; Puccetti E
PLoS One; 2011; 6(7):e22540. PubMed ID: 21811629
[TBL] [Abstract][Full Text] [Related]
11. Dimerization-induced corepressor binding and relaxed DNA-binding specificity are critical for PML/RARA-induced immortalization.
Zhou J; Pérès L; Honoré N; Nasr R; Zhu J; de Thé H
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9238-43. PubMed ID: 16757557
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of genome-wide PLZF/RARA target genes.
Spicuglia S; Vincent-Fabert C; Benoukraf T; Tibéri G; Saurin AJ; Zacarias-Cabeza J; Grimwade D; Mills K; Calmels B; Bertucci F; Sieweke M; Ferrier P; Duprez E
PLoS One; 2011; 6(9):e24176. PubMed ID: 21949697
[TBL] [Abstract][Full Text] [Related]
13. The PRC1 Polycomb group complex interacts with PLZF/RARA to mediate leukemic transformation.
Boukarabila H; Saurin AJ; Batsché E; Mossadegh N; van Lohuizen M; Otte AP; Pradel J; Muchardt C; Sieweke M; Duprez E
Genes Dev; 2009 May; 23(10):1195-206. PubMed ID: 19451220
[TBL] [Abstract][Full Text] [Related]
14. The integrity of the charged pocket in the BTB/POZ domain is essential for the phenotype induced by the leukemia-associated t(11;17) fusion protein PLZF/RARalpha.
Puccetti E; Zheng X; Brambilla D; Seshire A; Beissert T; Boehrer S; Nürnberger H; Hoelzer D; Ottmann OG; Nervi C; Ruthardt M
Cancer Res; 2005 Jul; 65(14):6080-8. PubMed ID: 16024608
[TBL] [Abstract][Full Text] [Related]
15. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
[TBL] [Abstract][Full Text] [Related]
16. IGF signaling contributes to malignant transformation of hematopoietic progenitors by the MLL-AF9 oncoprotein.
Jenkins CE; Shevchuk OO; Giambra V; Lam SH; Carboni JM; Gottardis MM; Holzenberger M; Pollak M; Humphries RK; Weng AP
Exp Hematol; 2012 Sep; 40(9):715-723.e6. PubMed ID: 22613471
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice.
Shing DC; Trubia M; Marchesi F; Radaelli E; Belloni E; Tapinassi C; Scanziani E; Mecucci C; Crescenzi B; Lahortiga I; Odero MD; Zardo G; Gruszka A; Minucci S; Di Fiore PP; Pelicci PG
J Clin Invest; 2007 Dec; 117(12):3696-707. PubMed ID: 18037989
[TBL] [Abstract][Full Text] [Related]
18. ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype.
Lucena-Araujo AR; Coelho-Silva JL; Pereira-Martins DA; Thomé C; Scheucher PS; Lange AP; Paiva HH; Hemmelgarn BT; Morais-Sobral MC; Azevedo EA; Franca-Neto PL; Franca RF; Silva CL; Krause A; Rego EM
Oncotarget; 2017 Jan; 8(5):8475-8483. PubMed ID: 28035072
[TBL] [Abstract][Full Text] [Related]
19. Transcription coactivator Eya2 is a critical regulator of physiological hypertrophy.
Lee SH; Kim J; Ryu JY; Lee S; Yang DK; Jeong D; Kim J; Lee SH; Kim JM; Hajjar RJ; Park WJ
J Mol Cell Cardiol; 2012 Mar; 52(3):718-26. PubMed ID: 22197309
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a humanized APL model via the transplantation of PML-RARA-transduced human common myeloid progenitors into immunodeficient mice.
Matsushita H; Yahata T; Sheng Y; Nakamura Y; Muguruma Y; Matsuzawa H; Tanaka M; Hayashi H; Sato T; Damdinsuren A; Onizuka M; Ito M; Miyachi H; Pandolfi PP; Ando K
PLoS One; 2014; 9(11):e111082. PubMed ID: 25369030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
